First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes.

International Journal of Obesity : Journal of the International Association for the Study of Obesity
E M VendittiDiabetes Prevention Program Research Group

Abstract

Following unblinding of the Diabetes Prevention Program (DPP) results, a 16-session lifestyle intervention program was offered to all study participants, including those who had initially been randomized to lifestyle treatment. This study compares the effects of the lifestyle program between participants who had previous exposure and those who had not. A 16-session behavioral intervention was conducted in groups at each of the 27 DPP sites during a transitional (bridge) period from the DPP trial to the DPP Outcomes Study (DPPOS). Session participation for this 6-month behavioral weight loss program was confirmed by originally randomized treatment groups. Independently assessed weight measurements were available within a 7-month period before and after the program for 2808 ethnically diverse participants. Participants from the lifestyle group in the DPP were the least likely to attend a repeat offering of a 16-session behavioral weight loss program conducted in groups. Weight loss during the transitional lifestyle program was strongly related to the duration of attendance in the three groups that were participating in the program for the first time (metformin, placebo and troglitazone), but not related to amount of earlier weigh...Continue Reading

References

Aug 1, 1971·Behaviour Research and Therapy·R B Stuart
Sep 12, 2001·Journal of Consulting and Clinical Psychology·M G PerriB J Viegener
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Sep 20, 2002·The American Psychologist·Janet Polivy, C Peter Herman
Nov 28, 2002·Diabetes Care·UNKNOWN Diabetes Prevention Program (DPP) Research Group
Feb 3, 2005·Obesity Research·Thomas A WaddenKirstin J Byrne
Jul 9, 2005·The American Journal of Clinical Nutrition·Rena R Wing, Suzanne Phelan
Aug 29, 2006·Diabetes Care·Richard F HammanJudith Wylie-Rosett
Oct 13, 2006·The New England Journal of Medicine·Rena R WingJoseph L Fava

❮ Previous
Next ❯

Citations

Feb 22, 2012·Current Diabetes Reports·Elizabeth M Venditti, M Kaye Kramer
Feb 2, 2013·Current Diabetes Reports·Kathleen A Page, Tamar Reisman
Jan 8, 2011·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Deborah J ToobertRussell E Glasgow
Jul 10, 2012·Nihon rinsho. Japanese journal of clinical medicine·Chikako Ito
Feb 14, 2014·The International Journal of Behavioral Nutrition and Physical Activity·Elizabeth M VendittiUNKNOWN Diabetes Prevention Program Research Group
Nov 11, 2014·Current Nutrition Reports·Mary A HoskinUNKNOWN for the Diabetes Prevention Program Research Group
Jun 27, 2013·Diabetes Care·William C Knowler, Ronald T Ackermann
Feb 21, 2016·Primary Care·Claire P KelleyTracy Sbrocco
Aug 21, 2014·Expert Opinion on Pharmacotherapy·Giuseppe DanieleRalph A DeFronzo
Oct 23, 2013·Journal of the Academy of Nutrition and Dietetics·Nichola J DavisUNKNOWN Diabetes Prevention Program Research Group
Jan 5, 2011·Diabetes Research and Clinical Practice·Karl K VanderwoodUNKNOWN Montana Cardiovascular Disease and Diabetes Prevention Workgroup
Aug 10, 2011·The American Journal of Cardiology·Ralph A DeFronzo, Muhammad Abdul-Ghani
May 16, 2014·Diabetic Medicine : a Journal of the British Diabetic Association·L M JaacksUNKNOWN Diabetes Prevention Program Research Group
Nov 10, 2011·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·John ArmatoRon Ruby
May 6, 2011·Diabetes Care·Ralph A DeFronzo, Muhammad Abdul-Ghani
Aug 16, 2016·Endocrinology and Metabolism Clinics of North America·Steven K Malin, Sangeeta R Kashyap
May 11, 2017·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·G A BrayUNKNOWN World Obesity Federation
Feb 18, 2010·American Journal of Lifestyle Medicine·Andrea L Dunn
Mar 16, 2018·International Journal of Environmental Research and Public Health·Maria L Alva
Mar 9, 2018·Endocrine Reviews·George A BrayThomas H Inge
Nov 7, 2018·The Journal of Clinical Endocrinology and Metabolism·Catherine KimUNKNOWN Diabetes Prevention Program Research Group
Apr 23, 2019·Annals of Internal Medicine·John W ApolzanUNKNOWN Diabetes Prevention Program Research Group
Jul 4, 2019·Australian and New Zealand Journal of Public Health·Anne C GrunseitAdrian Bauman
Jan 20, 2020·The Journal of Clinical Endocrinology and Metabolism·Catherine KimWilliam C Knowler
Jun 10, 2020·Endocrinology·Harvey J Grill
Jul 21, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·UNKNOWN Diabetes Prevention Program Outcomes Study Research GroupK E Watson
May 6, 2019·Endocrine Reviews·Antonino Di Pino, Ralph A DeFronzo
Sep 1, 2019·Medicina·Radia Marium Modhumi KhanYan Zhao
Jun 26, 2009·The American Journal of Clinical Nutrition·George A Bray
Dec 9, 2017·The Journal of Clinical Endocrinology and Metabolism·Catherine KimUNKNOWN Diabetes Prevention Program Outcomes Study Group
Feb 6, 2017·Current Diabetes Reports·Dina HafezJeffrey T Kullgren
Jun 27, 2020·BMC Public Health·Erika Bohn-GoldbaumAnne C Grunseit
Nov 24, 2020·Behavioral Medicine·Simon A MossNektarios Alexi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.